你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
Hybrid Moloney/Amphotropic murine leukemia virus (Mo/A-MuLv)
Hybrid Moloney/Amphotropic murine leukemia virus (Mo/A-MuLv)
规格:
货期:
编号:TS195762
品牌:Testobio
产品名称: Hybrid Moloney/Amphotropic murine leukemia virus (Mo/A-MuLv)
商品货号: TS195762
Classification: Retrovirus, Mammalian Type C Retrovirus, Mammalian Group, Amphotropic
Agent: Hybrid Moloney/Amphotropic murine leukemia virus (Mo/A-MuLv)
Strain: 4070A envelope strain
Applications:
Analytical methodologies
Pharmaceutical and Personal Care
Biosafety Level: 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format: frozen
Storage Conditions: Vapor phase of liquid nitrogen
Comments:
This virus produces foci of round cells on MiCL1(Mink S+L-) cell line, and plaques on PG-4 (feline S+L- cell line). This holding consists of persistently infected tk(-)NIH3T3 producer cells that shed the Mo/A-MLV virus.
Amphotropic
Effect on Host:
No CPE in NIH3T3 cells
Recommended Host: Recommended Host: This virus is continuously produced by the cell line in which it is shipped. No additional host is required; however, if desired the virus may be used to infect other cells, which are listed as alternate hosts.

Alternate Host(s): Many mammalian cell lines (murine, rat, human except certain bovine and hamster cells)
Growth Conditions: Incubation: 2 to 7 days at 37°C, a 5% CO2 in air atmosphere is recommended
Name of Depositor: CA Wilson
Source: Transfection of tk(-)NIH3T3 cells with molecular clone of MLV derived by A. Dusty Miller
References:

Miller AD, et al. Generation of helper-free amphotropic retroviurses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol. Cell. Biol. 5: 431-437, 1985. PubMed: 2985952

General Chapters: <1046> Cell and Gene Therapy Products - Analytical Methodologies. Rockville, MD: U.S. Pharmacopeia; USP USP34-NF29, 2011

首页 > 产品中心 > 微生物培养 > 菌株 > null > Hybrid Moloney/Amphotropic murine leukemia virus (Mo/A-MuLv)

Hybrid Moloney/Amphotropic murine leukemia virus (Mo/A-MuLv)

  • 货号: TS195762
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: Hybrid Moloney/Amphotropic murine leukemia virus (Mo/A-MuLv)
商品货号: TS195762
Classification: Retrovirus, Mammalian Type C Retrovirus, Mammalian Group, Amphotropic
Agent: Hybrid Moloney/Amphotropic murine leukemia virus (Mo/A-MuLv)
Strain: 4070A envelope strain
Applications:
Analytical methodologies
Pharmaceutical and Personal Care
Biosafety Level: 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format: frozen
Storage Conditions: Vapor phase of liquid nitrogen
Comments:
This virus produces foci of round cells on MiCL1(Mink S+L-) cell line, and plaques on PG-4 (feline S+L- cell line). This holding consists of persistently infected tk(-)NIH3T3 producer cells that shed the Mo/A-MLV virus.
Amphotropic
Effect on Host:
No CPE in NIH3T3 cells
Recommended Host: Recommended Host: This virus is continuously produced by the cell line in which it is shipped. No additional host is required; however, if desired the virus may be used to infect other cells, which are listed as alternate hosts.

Alternate Host(s): Many mammalian cell lines (murine, rat, human except certain bovine and hamster cells)
Growth Conditions: Incubation: 2 to 7 days at 37°C, a 5% CO2 in air atmosphere is recommended
Name of Depositor: CA Wilson
Source: Transfection of tk(-)NIH3T3 cells with molecular clone of MLV derived by A. Dusty Miller
References:

Miller AD, et al. Generation of helper-free amphotropic retroviurses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol. Cell. Biol. 5: 431-437, 1985. PubMed: 2985952

General Chapters: <1046> Cell and Gene Therapy Products - Analytical Methodologies. Rockville, MD: U.S. Pharmacopeia; USP USP34-NF29, 2011

合作单位: